THE PROGNOSTIC VALUE OF ELEVATED MONOCYTE-TO-LYMPHOCYTE RATIO AND LACTATE DEHYDROGENASE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
Multiple myeloma (MM) is a malignant blood cancer characterized by proliferation of plasma cells in bone marrow that is mainly composed by inflammatory cells. A prognostic effect can be assessed as consequence of alterations in peripheral blood leukocytes and the ratio between blood cells have been...
Main Authors: | LF Corral, L Kowalczuk, C Bundchen, SC Wagner, LN Rotta |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923009355 |
Similar Items
-
FATORES ENVOLVIDOS NA DECISÃO DE DOAR OU NÃO SANGUE POR ACADÊMICOS DA ÁREA DA SAÚDE
by: L Medeiros, et al.
Published: (2023-10-01) -
Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12
by: Francesco Autore, et al.
Published: (2019-06-01) -
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma
by: Melania Carlisi, et al.
Published: (2024-02-01) -
Acquired platelet dysfunction in newly diagnosed myeloma
by: Joshua Mortimer, et al.
Published: (2021-02-01) -
PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
by: Zhaoyun Liu, et al.
Published: (2023-08-01)